IMG_Aug62020at101252AM.jpg
New TechnologiesFractyl Raises $55M in Series E for Technology to Treat DiabetesFractyl Raises $55M in Series E for Technology to Treat Diabetes
The Lexington, MA-based company said it will use the proceeds to support the Revita T2Di pivotal clinical trial of the Revita DMR technology.
Sign up for the QMED & MD+DI Daily newsletter.